Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women

Research Group(s)

  • Cancer Biomarkers

Sponsor

M.D. Anderson Cancer Center

Status

Recruiting

ClinicalTrials.gov ID

For more information, see ClinicalTrials.gov NCT00539162

The goal of this clinical research study is to evaluate a method involving a blood test,
called CA-125, that may be helpful in the early detection of ovarian cancer in women who are
at low risk.

Intervention

Questionnaire

Condition

Ovarian Cancer

Investigators

Karen H. Lu, MD, Brian Slomovitz, MD

See list of participating sites